pharmaphorum4d
UCB, Biogen lupus drug scores in phase 3 trial
For Biogen, dapirolizumab pegol is part of a push ... "Our hypothesis is that impacting the CD40L pathway, a central mechanism in immune response, would translate to significant impact on SLE ...
Tonix’s TNX-1500 Shows Promise in Preventing Organ Transplant Rejections of Either Human or Pig Organs; Autoimmune Diseases Also a Target
The promise of CD40L blockers is to modulate the immune system rather than suppress it. Traditional immunosuppression drugs ...